NYSE · HEALTHCARE · Statistics
AbbVie Inc valuation and key ratios.
Valuation, profitability, balance-sheet health, and risk metrics for ABBV — each field resolved through TECHi's unified market-data layer.
Valuation
- Market cap
- $384.67B
- Enterprise value
- $447.90B
- P/E (TTM)
- 106.20
- Forward P/E
- 15.27
- PEG ratio
- 0.60
- Lower = cheaper for the growth
- Price / sales
- 6.12
- Price / book
- 50.46
- EPS (TTM)
- $2.05
Long-run compounding
CAGR since IPO and aggregate price growth.
Adjusted daily closes are annualized from the provider's historical price series; dividends are not included in this price-only return view.
- CAGR since IPO
- Pending
- From first adjusted close on January 2, 2013
- Aggregate CAGR
- 18.62%
- 1Y, 3Y, 5Y, 10Y blended CAGR
- First tracked close
- $20.56
- January 2, 2013
- History span
- 13 yrs
- Jan 2, 2013 to Jun 1, 2026 · 3,373 closes
- Latest tracked close
- $212.93
- June 1, 2026
- All-time high
- $244.81
- October 1, 2025
- All-time low
- $33.33
- January 10, 2013
- History source
- Long range
- Market data feed
Valuation map
Risk and scale
Pro formula stack
Ratios investors search for after the headline quote.
These are TECHi-computed from overview, income statement, balance sheet, and cash-flow rows when the market-data feed exposes the ingredients.
- EV / revenue
- 7.13
- Enterprise value / TTM revenue
- EV / EBITDA
- 26.47
- Enterprise value / EBITDA
- FCF yield
- 5.16%
- TTM free cash flow / market cap
- Earnings yield
- 0.94%
- Inverse P/E
- Rule of 40
- 44.04%
- Revenue growth + FCF margin
- ROIC approx.
- 18.59%
- NOPAT / invested capital
- CROIC
- 34.93%
- FCF / invested capital
- TECHi quality score
- 5 / 7
- 7-point profitability, cash, leverage, and trend check
Quality and capital returns
TTM free cash flow / TTM revenue
TTM FCF / TTM net income
Gross-profit productivity screen
TTM revenue / market cap
Balance-sheet and reinvestment reads
0.00 means net cash
Total debt / TTM FCF
Tech-stock reinvestment intensity
Capital intensity of the business
Distress and optionality read
ABBV Altman Z-score: 2.23.
TECHi computes a non-financial-company Altman-style score from working capital, retained earnings, EBIT, market value, liabilities, revenue, and assets. It is not a bankruptcy prediction, but it gives pro readers a fast stress screen that most quote pages do not show beside live valuation metrics.
- Altman Z-score
- 2.23
- Higher = stronger stress profile
- Net cash / share
- $-35.92
- Cash minus debt, per share
- Working capital
- -$8.57B
- Current assets minus current liabilities
- Debt growth YoY
- +4.25%
- Latest quarter vs same quarter last year
Valuation read
ABBV trades at 106.20× trailing earnings.
A trailing P/E above 30 means the market is paying up for ABBV. That premium has to be earned with above-average revenue or earnings growth — pair this with the forward P/E (15.27) and the PEG ratio (0.60) before forming a view.
Profitability
- Gross margin
- 72.03%
- Operating margin
- 32.20%
- Net margin
- 5.79%
- Return on equity
- 62.30%
- Return on assets
- 10.00%
- Debt / equity
- Pending
- Current ratio
- 0.80
- >1 = covers near-term liabilities
- Beta (5Y)
- Pending
Margin profile
Profitability read
ABBV converts 5.8% of revenue into net income.
Sub-8% net margins leave little cushion for input-cost shocks. Look for the operating-margin trend and the gross-margin floor — a stable gross with a recovering operating margin is the cleanest setup.
Per-share & range
- Dividend yield
- 3.08%
- Forward yield
- Shares outstanding
- 1.77B
- 52w high
- $244.81
- 52w low
- $181.73
Corporate actions
Stock split history
Provider split feed
- Latest split
- Pending
- No split events found
- Split events
- 0
- Latest split date
- Pending
- Split source
- Pending
Provider and filing fields
Company statistics fields
TECHi resolves these from the strongest available provider, then falls back to official SEC filing facts and live quote-derived formulas when provider APIs go empty.
- Revenue (TTM)
- $62.82B
- Market data feed
- Gross profit (TTM)
- $44.40B
- Market data feed
- EBITDA
- Pending
- Book value
- Pending
- Revenue / share
- Pending
- Earnings growth YoY
- Pending
- Revenue growth YoY
- Pending
- 50-day average
- Pending
- 200-day average
- Pending
- Dividend / share
- Pending
- Dividend date
- Pending
- Ex-dividend date
- Pending
Frequently asked
Common questions.
What is AbbVie Inc's market cap?
AbbVie Inc (ABBV) has a market capitalization of $384.7 billion, computed from the latest share count and the live ABBV quote price on TECHi.
What is ABBV's P/E ratio?
ABBV trades at a trailing P/E of 106.20. Forward P/E and PEG are visible alongside on the Statistics page; compare to the sector cohort on /quote/ABBV/peers/.
Where do TECHi's ABBV statistics come from?
Each metric on the ABBV Statistics page is resolved through TECHi's unified market-data layer and displayed only when the underlying field is available or can be computed cleanly.
How current is the ABBV statistics page?
Live quote-derived stats (52-week range, current ratio, beta) refresh every market session; reported fundamentals (margins, ROE, debt-to-equity) update each time the issuer files a new statement.